CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

icp-332

Small moleculeexperimental

Clinical trial activity

7 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started Aug 14, 2021 (NCT05399030)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2024

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07251998Phase 2Dec 31, 2025Beijing InnoCare Pharma Tech Co., Ltd., Shanghai Dermatology Hospital
NCT07236099Phase 2Nov 30, 2025Beijing InnoCare Pharma Tech Co., Ltd.
NCT07047612Phase 2/Phase 3 (Phase 3)May 9, 2025Beijing InnoCare Pharma Tech Co., Ltd.
NCT06775860Phase 3Nov 14, 2024Beijing InnoCare Pharma Tech Co., Ltd.
NCT06530966Phase 1Jul 23, 2024Beijing InnoCare Pharma Tech Co., Ltd.
NCT05702268Phase 2Mar 18, 2023Beijing InnoCare Pharma Tech Co., Ltd.
NCT05399030Phase 1Aug 14, 2021Beijing InnoCare Pharma Tech Co., Ltd., Jinan University
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Beijing InnoCare Pharma Tech Co., Ltd.For profit7732021
Jinan UniversityAcademic/Hospital1012021
Shanghai Dermatology HospitalAcademic/Hospital1012025
3 organizations
Page 1 / 1